Fusogenic-oligoarginine peptide-mediated silencing of the CIP2A oncogene suppresses oral cancer tumor growth in vivo
Authors:
- 1 November 2015
- journal article
- Published by Elsevier in Journal of Controlled Release
- Vol. 218, 72-81
Abstract
No abstract availableKeywords
Funding Information
- NIDCR (R00DE018191, T32DE017551)
- MUSC Center for Oral Health Research Laboratory Core (P30GM103331)
- Cell & Molecular Imaging Shared Resource, Hollings Cancer Center, MUSC (NCI P30CA138313)
This publication has 40 references indexed in Scilit:
- Fusogenic-Oligoarginine Peptide-Mediated Delivery of siRNAs Targeting the CIP2A Oncogene into Oral Cancer CellsPLOS ONE, 2013
- In Vitro Efficient Transfection by CM18-Tat11 Hybrid Peptide: A New Tool for Gene-Delivery ApplicationsPLOS ONE, 2013
- Improving the Endosomal Escape of Cell-Penetrating Peptides and Their Cargos: Strategies and ChallengesPharmaceuticals, 2012
- High CIP2A immunoreactivity is an independent prognostic indicator in early-stage tongue cancerBritish Journal of Cancer, 2011
- Design of a peptide-based vector, PepFect6, for efficient delivery of siRNA in cell culture and systemically in vivoNucleic Acids Research, 2011
- Delivery of siRNA Therapeutics: Barriers and CarriersThe AAPS Journal, 2010
- Protein Extraction of Formalin-fixed, Paraffin-embedded Tissue Enables Robust Proteomic Profiles by Mass SpectrometryJournal of Histochemistry & Cytochemistry, 2009
- Delivery of Macromolecules Using Arginine-Rich Cell-Penetrating Peptides: Ways to Overcome Endosomal EntrapmentThe AAPS Journal, 2009
- Structure of influenza haemagglutinin at the pH of membrane fusionNature, 1994
- Membrane Fusion by Peptide Analogues of Influenza Virus HaemagglutininJournal of General Virology, 1988